Delivery Order SPE2DB20D3103-SPE2DB25FL8F9

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of risperidone 0.25 mg tablets. The contract, valued at $1,514.21, is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,507.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567488250 - Risperidone 0.25 mg Tablets (60s), a generic medication used to treat certain mental/mood disorders. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 7, 2025. It is not designated...
This federal contract award, valued at $2,681.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,368.11 firm fixed-price delivery order is for the supply of 500 units of the drug Risperidone 0.25 mg tablet. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides...
This federal contract award, valued at $1,537.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Risperidone 0.25 mg tablets, a pharmaceutical product, to support DLA facilities and the Department of Defense (DoD) worldwide. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide Risperidone 0.25 mg tablets in quantities of 500 tablets per bottle. The $1,111.38 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $5,455.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, with an ultimate completion date of December 18, 2023. The contract covers the provision of 4563118140 - RISPERIDONE 0.5 MG TABLET 60S, a pharmaceutical product. This DO is part of a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,775.10, is for the delivery of 4,566,526,169 tablets of Risperidone 0.25 mg. It is a firm fixed-price delivery order contract with a completion date of November 25, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF1CB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,373.06 firm fixed-price delivery order is for the supply of 4,566,692,450 units of Risperidone 0.25 mg tablets, a medication used in the treatment of mental health conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Risperidone 0.5 mg tablets. The $3,253.35 firm fixed-price delivery order has a completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL8F9
    Delivery Order

This federal contract award, valued at $24,092.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566566549 - RISPERIDONE 0.25 MG TABLET 500S, a generic pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:15 PM